Á lódáil...
QbD Based Media Development for the Production of Fab Fragments in E. coli
Ranibizumab is a biotherapeutic Fab fragment used for the treatment of age-related macular degeneration and macular oedema. It is currently expressed in the gram-negative bacterium, Escherichia coli. However, low expression levels result in a high manufacturing cost. The protein expression can be in...
Na minha lista:
| Foilsithe in: | Bioengineering (Basel) |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
MDPI
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6631317/ https://ncbi.nlm.nih.gov/pubmed/30925730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/bioengineering6020029 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|